Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity
NCT ID: NCT04626570
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
154 participants
INTERVENTIONAL
2021-01-20
2025-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some authors have proposed that the concept of food addiction (i.e., the existence of an addiction to certain foods rich in sugar, fat and/or salt) may make it possible to identify, among obese patients, a subgroup of patients that is more homogeneous in terms of diagnosis and prognosis.
Food addiction is common in obese patients and is associated with higher levels of depression, anxiety, impulsivity, emotional eating and poorer quality of life. Nevertheless, we do not know the impact of managing this addiction on the future of these patients (food addiction, weight, comorbidities, quality of life). Telephone-based cognitive behavioral therapy intervention (Tele-CBT) is a treatment of choice for addictions, but there are inequalities in access to this treatment (distance between home and hospital, limited local resources of caregivers, constraints in patient availability) which require the therapeutic framework to be adapted to these constraints. A short Tele-CBT program has demonstrated its effectiveness in reducing bulimic hyperphagia in these patients (Cassin et al. 2016), but its effectiveness on food addiction, Body Mass Index and the evolution of metabolic complications related to obesity is still unknown. The evaluation of this program was limited to 6 weeks (American study), and we do not know if these results can also be extrapolated to France.
The main hypothesis of this study is that in patients suffering from severe or morbid obesity and with food addiction, the performance of tele-CBT (intervention group: 12 sessions for 18 weeks) will be accompanied by a significant medium-term decrease in the prevalence of food addiction compared to usual management (control group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals
NCT06632171
A Psychological and Behavioral Intervention for Post-Bariatric Patients
NCT01453517
Monitoring Obese Patients : Impact on the Frequency of Monitoring Weight
NCT02374866
Evaluation of the Care Pathway Offered by the "Chronic Disease Unit" to Obese Patients
NCT06538220
Reduction of Emotional Eating After a Behavior Change Program in Obesity
NCT01997697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Some authors have proposed that the concept of food addiction (i.e., the existence of an addiction to certain foods rich in sugar, fat and/or salt) may make it possible to identify, among obese patients, a subgroup of patients that is more homogeneous in terms of diagnosis and prognosis.
Food addiction is common in obese patients and is associated with higher levels of depression, anxiety, impulsivity, emotional eating and poorer quality of life. Nevertheless, we do not know the impact of managing this addiction on the future of these patients (food addiction, weight, comorbidities, quality of life). Telephone-based cognitive behavioral therapy intervention (Tele-CBT) is a treatment of choice for addictions, but there are inequalities in access to this treatment (distance between home and hospital, limited local resources of caregivers, constraints in patient availability) which require the therapeutic framework to be adapted to these constraints. A short Tele-CBT program has demonstrated its effectiveness in reducing bulimic hyperphagia in these patients (Cassin et al. 2016), but its effectiveness on food addiction, Body Mass Index and the evolution of metabolic complications related to obesity is still unknown. The evaluation of this program was limited to 6 weeks (American study), and we do not know if these results can also be extrapolated to France.
The main hypothesis of this study is that in patients suffering from severe or morbid obesity and with food addiction, the performance of tele-CBT (intervention group: 12 sessions for 18 weeks) will be accompanied by a significant medium-term decrease in the prevalence of food addiction compared to usual management (control group).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive and Behavioural Therapy plus Management as usual
12 sessions of CBT during 18 weeks AND management of obesity with nutritional and dietary treatment as usual
Cognitive and Behavioral Therapy
12 sessions of CBT using a standardized approach
Management as usual
management of obesity with nutritional and dietary treatment as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive and Behavioral Therapy
12 sessions of CBT using a standardized approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥35kg/m² (morbid or severe obesity)
* First appointment to a physician specialized in nutrition
* "Food addiction diagnosis" according to the YFAS 2.0
* Affiliated to the French national health service
* Consent signed
Exclusion Criteria
* Impossibility to participate to the CBT sessions (i.e., no phone, scheduled unavailability)
* Not eligible for CBT (i.e., cognitive disorders, hearing disorders)
* Antecedent of monogenic or oligogenic obesity (MC4R mutation)
* Severe alcohol use disorder (at least 6 out of 11 DSM-5 criteria for alcohol use disorder)
* Current medication with a significant adverse effect on eating behavior (i.e., lithium, neuroleptic/antipsychotic)
* Discrepancy between self-administered questionnaires and the clinical interview conducted prior to inclusion (for the assessment of food addiction diagnosis).
* Condition associated with important weight variations (i.e., oedema related to severe cardiac insufficiency, renal insufficiency, hepatic insufficiency with cirrhosis, exudative enteropathy)
* Participation to another psychological or pharmacological interventional study that could impact our primary or secondary outcomes
* Wearing a pace-maker or metal prosthesis
* Person under tutorship or curatorship
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul BRUNAULT, MD
Role: STUDY_DIRECTOR
University Hospital, Tours
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of endocrinology-diabetology-nutrition, University Hospital, Angers
Angers, , France
Nutrition Department, University Hospital, Brest
Brest, , France
Transversal Clinical Nutrition Unit, University Hospital, Caen
Caen, , France
Transversal Nutrition Unit, Hospital, Cherbourg
Cherbourg, , France
Nutrition Department, University Hospital, Nantes
Nantes, , France
Department of Internal Medicine, Endocrinology and Metabolic Diseases, University Hospital, Poitiers
Poitiers, , France
Endocrinology, diabetology and nutrition department, University Hospital, Reims
Reims, , France
Endocrinology, diabetology and nutrition department, University Hospital, Rennes
Rennes, , France
Metabolic and nutritional exploration, University Hospital, Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02773-54
Identifier Type: OTHER
Identifier Source: secondary_id
DR190068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.